Skip directly to the search box, site navigation, or content.
Division of Foodborne, Bacterial and Mycotic Diseases (DFBMD)
Cryptococcus (Cryptococcosis)
References
Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin N Am 2006; 20: 507-44.
Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499-508.
Hajjeh RA, Brandt ME, Pinner RW. Emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery. Epidemiol Rev 1996;17:303-320.
Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999;179:449-454.
MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007; 13: 42-50.
Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794.
Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus- negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33: 690-699.
Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16: 837-874.
Saag MS, Graybill JR, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-718.
Upton A, Fraser JA, Kidd SE, et al. First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J Clin Microbiol 2007; 45: 3086-8.
Content Source: National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED)
Program Contents
Contact Information
